Ausun Pharma is Biotechnology in China that focus on pharmaceutical intermediates business. Founded in 2010. They cover business area such as Zhejiang Ausun Pharmaceutical Co Ltd, development, production, sale, specialty api, pharmaceutical intermediate, research, customer, its product portfolio, prostaglandin, their intermediate, raw material medicine, Fluorine series, Develop.
2010
( 14 years old in 2024 )
Pharmaceutical Intermediates
-
Number 5, Donghai 4th Avenue
Zhejiang Chemcial Materials Base Zone
Linhai, Zhejiang 317016
China
Private
Zhejiang Ausun Pharmaceutical Co Ltddevelopmentproductionsalespecialty apipharmaceutical intermediateresearchcustomerits product portfolioprostaglandintheir intermediateraw material medicineFluorine seriesDevelop
* We use standard office opening hours in near Ausun Pharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ausun Pharma is Biotechnology business from China that founded in 2010 (14 years old in 2024), Ausun Pharma business is focusing on Pharmaceutical Intermediates.
Ausun Pharma headquarter office and corporate office address is located in Number 5, Donghai 4th Avenue Zhejiang Chemcial Materials Base Zone Linhai, Zhejiang 317016 China.
Ausun Pharma was founded in China.
In 2024, Ausun Pharma is currently focus on pharmaceutical intermediates sector.
Above is snippet of Google Trends for "pharmaceutical intermediates" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ausun Pharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
